NPPA notified regarding the fixing/revising the price of Chloroquine

Sep 13, 2024 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on September 10, 2024, issued the notification regarding the fixing/revising the price including WPI impact.

The following has been stated namely: -

• The price has been fixed/revised including WPI impact @0.00551% for the year 2024

• The ceiling price exclusive of Goods and Services Tax applicable has been stated.

• The price of the medicine Chloroquine has been fixed at 1.33

• The ceiling price for a pack of the scheduled formulation shall be arrived at by the concerned manufacturer in accordance with the ceiling price specified

• The manufacturers of above said scheduled formulations shall furnish quarterly return to the NPPA, in respect of production/import and sale of scheduled formulations

[Notification No. S.O. 3868(E)]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT